자료실

국제 식량농업 뉴스


[FDA] Coronavirus (COVID-19) Update: February 19, 2021
  • 작성자 : 관리자
  • 작성일 : 2021-02-22 13:28:17
  • 조회수 : 24

 

Coronavirus (COVID-19) Update: February 19, 2021

19 February 2021

 

 

the FDA approved two abbreviated new drug applications (ANDAs) for piperacillin and tazobactam for injection (ANDAs 208674 and 208675), indicated to treat intra-abdominal infections in adult and pediatric patients 2 months of age and older, nosocomial pneumonia in adult and pediatric patients 2 months of age and older, skin and skin structure infections in adults, female pelvic infections in adults and community-acquired pneumonia in adults. 

 

The most common side effects of piperacillin and tazobactam for injection are diarrhea, constipation, nausea, headache and insomnia. ·​·(중략)

   

  ​

 

원문 바로보기  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-february-19-2021

 

 

 ​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​ ​ ​​​​​ ​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​​ ​​​​​​​​​​ ​​​​​​​​ ​ ​​​ ​​​​ ​ ​ ​ ​​​ ​​​​​ ​​ ​​​​​​​​​ ​​​​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​ ​ ​​​​​ ​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​​ ​​​​​​​​​​ ​​​​​​​​ ​ ​​​ ​​​​ ​ ​ ​ ​​​ ​​​​​ ​​ ​​​​​​​​​ ​​​​​ ​​​​​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​ ​ ​​​​​ ​​​​​​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​​ ​​​​​​​​​​ ​​​​​​​​ ​ ​​​ ​​​​ ​ ​ ​ ​​​ ​​​​​ ​​ ​​​​​​​​​ ​​​​​ ​​​​​​​​ ​ ​​​​​​​​​ ​​​​​​​​​​​​ ​ ​​​​​​​​​​ ​ ​​​​​ ​​​​​​​​ ​​​ ​​​​​​​​​​​​​​ ​ ​​​​​ ​​​​​​​​​​​​​​​​​​ ​​​​​ ​